Biogen Inc - Company Profile
Powered by 
All the data and insights you need on Biogen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Biogen Inc Strategy Report
- Understand Biogen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Biogen Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022218560A1 | Application | Benzoazepine analogs as inhibiting agents for Bruton's tyrosine kinase | A61K31/55; A61P1/16; A61P43/00; C07B2200/13; C07D403/14; C07D405/14; C07D413/14; C07D417/14; C07D471/04 | September 15, 2022 |
| EP3797780B1 | Grant | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION DER SMN2-AUFSPALTUNG IN EINEM PATIENTEN | C12N15/113; C12N2310/11; C12N2310/315; C12N2310/322; C12N2310/3341; C12N2310/343; C12N2310/346; C12N2320/33 | September 14, 2022 |
| CN109689037B | Grant | 利用SUR1-TRPM4通道抑制剂的医学治疗方法 | A61K31/4045; A61K31/64; A61K31/7076; A61K38/482; A61K38/4893; A61K38/49; A61K45/06; A61K9/0053; A61K9/7023; A61N5/1084; A61P25/00; A61P25/06; A61P29/00; A61P9/10; C12Y304/21068; C12Y304/21069; C12Y304/24069 | September 13, 2022 |
| WO2022187567A2 | Application | LOW-SORBING GLYBURIDE FORMULATION AND METHODS | A61K31/64; A61K47/18; A61K47/26; A61K9/0019; A61K9/19 | September 09, 2022 |
| US20220280548A1 | Application | COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY | A61K31/7125; A61K48/005; A61P21/00; C12N15/113 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer